# TERBUTALINE SULFATE
> **ANDA211832** · Abbreviated New Drug Application (Generic) · Sponsor: TWI PHARMS · Approved 2020-06-19
## Drug
- **FDA Application Number:** ANDA211832
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TERBUTALINE SULFATE
- **Generic name:** TERBUTALINE SULFATE
- **Active ingredients:** TERBUTALINE SULFATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TWI PHARMS
- **Manufacturer:** Upsher-Smith Laboratories, LLC
- **First approval:** 2020-06-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211832)
---
*AI Analytics · CC0 1.0*